ABIOMED Inc

Abiomed, Inc. is a company dedicated to the research, development, and commercialization of medical devices designed to either aid or completely take over the pumping function of a failing heart. They also offer continuous support for heart failure patients. The core of their product line consists of the Impella family of micro heart pumps. These include the Impella 2.5, a percutaneous device featuring an integrated motor and sensors. Another key offering is the Impella CP, which interventional cardiologists use in catheterization labs and cardiac surgeons deploy in operating rooms to provide circulatory assistance. More advanced Impella models, such as the 5.0, LD, and 5.5, are also percutaneous micro heart pumps with internal motor and sensor technology, primarily utilized in heart surgery suites. For specific needs, the Impella RP is a percutaneous, catheter-based axial flow pump. Beyond the pumps themselves, Abiomed offers sophisticated platforms like Impella SmartAssist, which uses optical sensor technology for precise pump placement and algorithms to better evaluate the native heart during the patient weaning process. Additionally, Impella Connect is a cloud-based solution enabling physicians and hospital staff to securely monitor the automated Impella controller remotely. The company also provides the OXY-1 System, a portable external device for respiratory assistance. Looking to the future, Abiomed is actively developing several innovative products. These include the Impella ECP, a pump designed to achieve blood flow rates exceeding three liters per minute; the Impella XR Sheath, a unique sheath that expands and then recoils to allow small-bore access and closure for Impella heart pumps; the Impella BTR, another percutaneous micro heart pump; and preCARDIA, a catheter-mounted superior vena cava therapy system aimed at rapidly treating acutely decompensated heart failure. Abiomed, Inc. distributes its products globally through its direct sales force and clinical support teams, reaching markets across Germany, France, the United States, Japan, other European nations, Canada, Latin America, the Asia-Pacific region, and the Middle East. The company was established in 1981 and operates from its headquarters in Danvers, Massachusetts.